Evidence map›Paper›PMID 33114743›Full record

ArticleJournal of clinical medicine2020

The Extended Utility of CHA

Witold Streb, Katarzyna Mitręga, Stanisław Morawski, Wiktoria Kowalska, Zbigniew Kalarus

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Witold StrebDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy SUM, Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.ORCID 0000-0003-4856-8511
Katarzyna MitręgaDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy SUM, Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.
Stanisław MorawskiDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy SUM, Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.
Wiktoria KowalskaDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy SUM, Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.ORCID 0000-0001-5064-8217
Zbigniew KalarusDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy SUM, Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.
Silesian Center for Heart Disease · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeLeft atrial appendage closure (LAAC) is an option for stroke prevention in atrial fibrillation patients. Randomized studies have demonstrated the effectiveness and safety of LAAC but included patients with an average risk of stroke and bleeding complications. The current study aimed to assess the extended utility of CHA

methodsThe study population comprised 270 patients aged 72.8 ± 8.78 years. The occluders used were the Amplatzer Amulet (

resultsThe observed rates of ischemic stroke and bleeding were much lower than that expected (2.2% vs. 5.6%, and 0.76% vs. 6.05%, respectively). The mortality rate did not differ concerning the CHA

conclusionsHAS-BLED, but not CHA

Indexed as

atrial appendageatrial fibrillationleft atrial appendage closureprognosisstroke

Identifiers

PMID33114743
PMCPMC7692802
OpenAlexW3096659873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.